BioVentures — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US
Bill Fawcett(Co-founder)Natalie Wisniewski(Executive Officer, Director)inBill McMillan(Co-Founder, CSO & Head of Research)Ben Healy(CEO)Ben Hwang(Chairman & CEO)in
Board seatQianye Karen Liu· per SEC Form D · $17M raise · filed Jul 2015
Co-investors3E Bioventures CapitalAsset Management CompanyAtinum Investment Co. Ltd.Sand Hill Angels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




